Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers
Date
2016Author
Fujio, Sayaka [Universidad de Chile. INTA]
Navarrete, Paola [Universidad de Chile. INTA]
Ugalde, Juan A. [Chile. Universidad Mayor. Centro de Genómica y Bioinformática]
Magne, Fabien [Universidad de Chile]
Carrasco-Pozo, Catalina [Universidad de Chile. Facultad de Medicina]
Tralma, Karina [Universidad de Chile. Facultad de Medicina]
Quezada, María Paz [Universidad de Chile. Facultad de Medicina]
Hurtado, Carmen [Universidad de Chile]
Covarrubias, Natalia [Universidad de Chile]
Brignardello, Jerusa [Universidad de Chile. INTA]
Henríquez, Daniela [Universidad de Chile. INTA]
Gotteland, Martin [Universidad de Chile. Facultad de Medicina]
Geographic location
Note
Tools
Abstract
OBJECTIVES: High-fat diets alter gut microbiota and barrier function, inducing metabolic endotoxemia and low-grade inflammation. Whether these effects are due to the high dietary lipid content or to the concomitant decrease of carbohydrate intake is unclear. The aim of this study was to determine whether higher amounts of dietary fat reaching the colon (through orlistat administration) affect the colonic ecosystem in healthy volunteers and the effect of the prebiotic oligofructose (OF) in this model. METHODS: Forty-one healthy young subjects were distributed among four groups: Control (C), Prebiotic (P), Orlistat (O), and Orlistat/Prebiotic (OP). They consumed a fat-standardized diet (60 g/day) during Week-1 (baseline) and after 1 week of washout, Week-3. During Week-3, they also received their respective treatment (Orlistat: 2 × 120 mg/day, OF: 16 g/day, and maltodextrin as placebo). A 72-h stool collection was carried out at the end of Week-1 (T0) and Week-3 (T1). Fecal fat, calprotectin, and short-chain fatty acids (SCFAs) as well as the antioxidant activity of fecal waters (ferric-reducing antioxidant power), fecal microbiota composition (by deep sequencing), and gut permeability (Sucralose/Lactulose/Mannitol test) were determined at these times. RESULTS: Fecal fat excretion was higher in the O (P=0.0050) and OP (P=0.0069) groups. This event was accompanied, in the O group, by an increased calprotectin content (P=0.047) and a decreased fecal antioxidant activity (P=0.047). However, these alterations did not alter gut barrier function and the changes observed in the composition of the fecal microbiota only affected bacterial populations with low relative abundance (<0.01%); in consequences, fecal SCFA remained mainly unchanged. Part of the colonic alterations induced by orlistat were prevented by OF administration. CONCLUSIONS: In the context of an equilibrated diet, the acute exposition of the colonic ecosystem to high amounts of dietary lipids is associated with an incremented excretion of fecal calprotectin and pro-oxidant activity of the colonic content, in the absence of significant changes in the microbiota.
URI
https://www.nature.com/articles/ctg201620.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855161/pdf/ctg201620a.pdf
https://dx.doi.org/10.1038/ctg.2016.20
http://repositorio.umayor.cl/xmlui/handle/sibum/2608
Collections
Si usted es autor(a) de este documento y NO desea que su publicación tenga acceso público en este repositorio, por favor complete el formulario aquí.
Related items
Showing items related by title, author, creator and subject.
-
Aberrant localization of fusion receptors involved in regulated exocytosis in salivary glands of Sjogren's syndrome patients is linked to ectopic mucin secretion.
Barrera, María José [Universidad de Chile]; Sánchez, Marianela [Universidad de Chile]; Aguilera, Sergio [Chile. Clínica INDISA]; Alliende, Cecilia [Universidad de Chile]; Bahamondes, Verónica [Universidad de Chile]; Molina, Claudio [Chile. Universidad Mayor]; Leyton, Cecilia [Universidad de Chile]; Quest, Andrew F.G. [Universidad de Chile]; Urzúa, Ulises [Universidad de Chile]; Castro, Isabel [Universidad de Chile]; González, Sergio [Chile. Universidad Mayor]; Sung, Hsiao Hsin [Universidad de Chile]; Albornoz, Amelina [Universidad de Chile]; Hermoso, Marcela [Universidad de Chile]; González, María-Julieta [Universidad de Chile] (Facultad de Ciencias, 2012)Sjögren's syndrome (SS) is a chronic inflammatory autoimmune disease that mainly affects tear and salivary glands, whereby SS-patients frequently complain of eye and mouth dryness. Salivary acinar cells of SS-patients ... -
Oral dryness in Sjogren's syndrome patients: Not just a question of water
Sepulveda, D [Universidad de Chile]; Cortes, J. [Universidad de Chile]; Quest, Andrew F.G [Universidad de Chile]; Barrera,MJ [Universidad de Chile]; Bahamondes, V. [Universidad de Chile]; Aguilera, S [Clínica INDISA, Chile]; Urzúa, Ulises [Universidad de Chile]; Alliende,C. [Universidad de Chile]; Molina, C. [Chile. Universidad Mayor]; González, S. [Chile. Universidad Mayor]; Hermoso, M.A. [Universidad de Chile]; Leyton, C. [Universidad de Chile] (CIENCIAS, 2013)Sjögren's syndrome (SS) is a chronic autoimmune disease of undefined etiology. Patients with this syndrome suffer from severe alterations in both the quality and quantity of saliva and tears, due to impaired function of ... -
Rational Design, Synthesis and Evaluation of CD-Containing as a Prednisone Delivery Platform
Marican, Adolfo [Chile. Universidad de Talca]; Valdéz, Oscar [Chile. Universidad Católica del Maule]; Wehinger, Sergio [Chile. Universidad de Talca]; Villaseñor, Jorge [Chile. Universidad de Talca]; Fuentealba, Natalia [Chile. Universidad de Talca]; Arenas-Salinas, Mauricio [Chile. Universidad de Talca]; Argandoña, Yerko [Chile. Universidad de Talca]; Carrasco-Sánchez, Verónica [Chile. Universidad de Talca]; Durán-Lara, Estebán F. [Chile. Universidad de Talca]; Avila-Salas, F. [Chile. Universidad Mayor. Facultad de Ciencias. Centro de Nanotecnología Aplicada] (Facultad de Ciencias, 2018)This study describes the in-silico rational design, synthesis and evaluation of cross-linked polyvinyl alcohol hydrogels containing γ-cyclodextrin (γ-CDHSAs) as platforms for the sustained release of prednisone (PDN). ...